In one paragraphArticle in ACS chemical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Cassandra J HatzipantelisInstitute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.ORCID 0000-0001-5376-7887 Lindsay P CameronNeuroscience Graduate Program, University of California Davis, Davis, California 95618, United States.
Min LiuInstitute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.ORCID 0000-0002-4698-6667 Seona D PatelDepapment of Chemistry, University of California Davis, Davis, California 95616, United States.ORCID 0000-0001-8947-4533 Hannah N SaegerPharmacology and Toxicology Graduate Program, University of California Davis, Davis, California 95616, United States.
Anna M M VernierInstitute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.
Yara A KhatibInstitute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.
Brandon J WillisMouse Biology Program, University of California Davis, Davis, California 95616, United States.
Louise LanoueMouse Biology Program, University of California Davis, Davis, California 95616, United States.
Oliver FiehnInstitute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.ORCID 0000-0002-6261-8928 David E OlsonInstitute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.ORCID 0000-0002-4517-0543 Funding
KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium TCP Transfer to UC DavisUM1OD023221 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2016 to 2026
$45.7MUCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2MKOMP Phase II Mouse Production and CryopreservationU42OD011175 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2012 to 2015
$18.9MENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9MLearning, Memory, and Plasticity (LaMP) Training ProgramT32MH112507 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Karen Zito · 2017 to 2026
$2.4MNIEHS NIH HHS T32 ES007059NIH HHS U42 OD011175NIH HHS U42 OD012210NIH HHS UM1 OD023221NIMH NIH HHS T32 MH112507
6 · The paper itselfAbstract
Exogenously administered psychedelics produce both rapid and long-lasting effects on neuroplasticity and behavior, but it is currently unclear if endogenously produced psychedelics can elicit similar effects. There have been relatively few studies on the role of endogenous psychedelics in health and disease, perhaps owing to the difficulty in quantifying their levels and manipulating their production. Here, we describe highly sensitive mass spectrometry-based analytical methods for quantifying endogenous psychedelics in mice, and we disclose a genetic mouse model lacking indolethylamine
Indexed as
Behavior, AnimalHallucinogensMethyltransferasesTryptaminesAnimalsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutHallucinogensMethyltransferasestryptamineTryptaminesbufotenineDMTindolethylamine N-methyltransferaseINMTN,N-dimethyltryptaminepsychedelicTEMTthioether S-methyltransferase
Identifiers
PMID41016016
PMCPMC12626434
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390